4 days Ago By ABMN Staff
Wells Fargo & Company MN raised its stake in VanEck Biotech ETF ( NASDAQ:BBH – Free Report ) by 5.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,826 shares of the company’s stock after acquiring an additional 4,064 shares during the period.
Wells Fargo & Company MN’s holdings in VanEck Biotech ETF were worth $11,902,000 at the end of the most recent quarter. Several other institutional investors and hedge funds have also bought and sold shares of the company. Jane Street Group LLC increased its position in VanEck Biotech ETF by 401.
7% during the 3rd quarter. Jane Street Group LLC now owns 8,348 shares of the company’s stock worth $1,481,000 after purchasing an additional 6,684 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of VanEck Biotech ETF in the third quarter valued at approximately $166,000.
Janney Montgomery Scott LLC acquired a new stake in VanEck Biotech ETF during the 4th quarter worth approximately $481,000. Flagship Harbor Advisors LLC grew its holdings in VanEck Biotech ETF by 12.1% during the 4th quarter.
Flagship Harbor Advisors LLC now owns 1,984 shares of the company’s stock worth $311,000 after acquiring an additional 214 shares during the last quarter. Finally, Strategic Financial Concepts LLC bought a new stake in VanEck Biotech ETF during the 4th quarter worth approximately $3,828,000. Institutional investors own 32.
05% of the company’s stock. VanEck Biotech ETF Stock Down 0.6 % Shares of NASDAQ:BBH opened at $147.
74 on Wednesday. The business has a fifty day simple moving average of $158.38 and a 200 day simple moving average of $163.
58. VanEck Biotech ETF has a 12-month low of $135.34 and a 12-month high of $183.
64. The firm has a market cap of $342.76 million, a P/E ratio of 29.
88 and a beta of 0.85. About VanEck Biotech ETF The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS.
The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry. Featured Articles Want to see what other hedge funds are holding BBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Biotech ETF ( NASDAQ:BBH – Free Report ).
Receive News & Ratings for VanEck Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter ..
